BIOGEN INC. Quarterly Other Assets, Current in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Biogen Inc. quarterly Other Assets, Current history and growth rate from Q1 2010 to Q3 2024.
  • Biogen Inc. Other Assets, Current for the quarter ending September 30, 2024 was $674M, a 30.8% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $674M -$300M -30.8% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $615M -$281M -31.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.17B -$247M -17.5% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $1.18B -$236M -16.6% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $974M -$521M -34.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $896M -$749M -45.5% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 $1.41B +$485M +52.3% Mar 31, 2023 10-Q 2023-04-25
Q4 2022 $1.42B +$677M +91.4% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $1.5B +$759M +103% Sep 30, 2022 10-Q 2022-10-25
Q2 2022 $1.65B +$877M +114% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $927M +$141M +18% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $741M -$140M -15.9% Dec 31, 2021 10-K 2023-02-15
Q3 2021 $736M +$52.8M +7.73% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $768M +$129M +20.2% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $786M +$102M +15% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $881M +$250M +39.6% Dec 31, 2020 10-K 2022-02-03
Q3 2020 $684M -$59.7M -8.03% Sep 30, 2020 10-Q 2020-10-21
Q2 2020 $639M -$342M -34.8% Jun 30, 2020 10-Q 2020-07-22
Q1 2020 $684M -$282M -29.2% Mar 31, 2020 10-Q 2020-04-23
Q4 2019 $631M -$56.6M -8.23% Dec 31, 2019 10-K 2021-02-03
Q3 2019 $743M -$105M -12.4% Sep 30, 2019 10-Q 2019-10-22
Q2 2019 $980M +$137M +16.3% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $965M +$69.5M +7.76% Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $688M -$274M -28.5% Dec 31, 2018 10-K 2020-02-06
Q3 2018 $848M -$119M -12.3% Sep 30, 2018 10-Q 2018-10-23
Q2 2018 $843M -$303M -26.4% Jun 30, 2018 10-Q 2018-07-24
Q1 2018 $896M -$336M -27.3% Mar 31, 2018 10-Q 2018-04-24
Q4 2017 $962M -$131M -12% Dec 31, 2017 10-K 2019-02-06
Q3 2017 $967M -$26.1M -2.63% Sep 30, 2017 10-Q 2017-10-24
Q2 2017 $1.15B +$119M +11.6% Jun 30, 2017 10-Q 2017-07-25
Q1 2017 $1.23B +$291M +30.9% Mar 31, 2017 10-Q 2017-04-25
Q4 2016 $1.09B +$256M +30.6% Dec 31, 2016 10-K 2018-02-01
Q3 2016 $993M +$131M +15.2% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $1.03B +$277M +37% Jun 30, 2016 10-Q 2016-07-21
Q1 2016 $941M +$362M +62.4% Mar 31, 2016 10-Q 2016-04-21
Q4 2015 $837M +$527M +170% Dec 31, 2015 10-K 2017-02-02
Q3 2015 $862M +$465M +117% Sep 30, 2015 10-Q 2015-10-21
Q2 2015 $750M +$403M +116% Jun 30, 2015 10-Q 2015-07-24
Q1 2015 $580M +$284M +96.3% Mar 31, 2015 10-Q 2015-04-24
Q4 2014 $310M +$83.7M +37% Dec 31, 2014 10-K 2016-02-03
Q3 2014 $396M +$191M +92.8% Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $347M +$173M +99.6% Jun 30, 2014 10-Q 2014-07-23
Q1 2014 $295M +$125M +73.7% Mar 31, 2014 10-Q 2014-04-23
Q4 2013 $226M +$90.1M +66.3% Dec 31, 2013 10-K 2015-02-04
Q3 2013 $206M +$79.5M +63% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $174M +$24.5M +16.4% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $170M +$47.8M +39.2% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $136M -$8.59M -5.94% Dec 31, 2012 10-K 2014-02-06
Q3 2012 $126M -$68M -35% Sep 30, 2012 10-Q 2012-10-25
Q2 2012 $149M -$52.5M -26% Jun 30, 2012 10-Q 2012-07-24
Q1 2012 $122M -$64.2M -34.4% Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $145M -$71.2M -33% Dec 31, 2011 10-K 2013-02-05
Q3 2011 $194M -$4.71M -2.37% Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $202M -$16.9M -7.71% Jun 30, 2011 10-Q 2011-07-26
Q1 2011 $186M -$24M -11.4% Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $216M Dec 31, 2010 10-K 2012-02-03
Q3 2010 $199M Sep 30, 2010 10-Q 2010-10-26
Q2 2010 $219M Jun 30, 2010 10-Q 2010-07-20
Q1 2010 $210M Mar 31, 2010 10-Q 2010-04-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.